References
Cai N, Li C (2019) Silencing of LncRNA-ANCR promotes the osteogenesis of osteoblast cells in postmenopausal osteoporosis via targeting EZH2 and RUNX2. Yonsei Med J 60:751–759
Charbord P, Livne E, Gross G, Haupl T, Neves NM, Marie P, Bianco P, Jorgensen C (2011) Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev Rep 7:32–42
Chen P, Lin C, Quan J, Lai Y, He T, Zhou L, Pan X, Wu X, Wang Y, Ni L, Yang S, Wang T, Lai Y (2017) Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma. Mol Med Rep 16:5023–5030
Coughlan T, Dockery F (2014) Osteoporosis and fracture risk in older people. Clin Med 14:187–191
Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K (2017) miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy. Cancer Med 6:2252–2262
Ensrud KE, Crandall CJ (2017) Osteoporosis. Ann Intern Med 167:Itc17–itc32
Eriksen EF, Diez-Perez A, Boonen S (2014) Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 58:126–135
Feng L, **a B, Tian BF, Lu GB (2019) MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR. Pharm Biol 57:586–594
Fu YC, Zhao SR, Zhu BH, Guo SS, Wang XX (2019) MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3. Eur Rev Med Pharmacol Sci 23:73–80
Gan D, Xu X, Chen D, Feng P, Xu Z (2019) Network pharmacology-based pharmacological mechanism of the Chinese medicine Rhizoma drynariae against osteoporosis. Med Sci Monit 25:5700–5716
Ha H, Ho J, Shin S, Kim H, Koo S, Kim IH, Kim C (2003) Effects of Eucommiae cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch Pharm Res 26:929–936
Han Y, Zhang K, Hong Y, Wang J, Liu Q, Zhang Z, **a H, Tang Y, Li T, Li L, Xue Y, Hong W (2018) miR-342-3p promotes osteogenic differentiation via targeting ATF3. FEBS Lett 592:4051–4065
He QL, Qin SY, Tao L, Ning HJ, Jiang HX (2019) Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: a comprehensive study based on 1,258 samples. Oncol Lett 18:6126–6142
Jakob M, Mattes LM, Kuffer S, Unger K, Hess J, Bertlich M, Haubner F, Ihler F, Canis M, Weiss BG (2019) MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Head Neck-J Sci Spec 41:3499–3515
Kelch S, Balmayor ER (2017) miRNAs in bone tissue correlate to bone mineral density and circulating miRNAs are gender independent in osteoporotic patients. Sci Rep 7:15861
Komori T (2017) Roles of Runx2 in skeletal development. Adv Exp Med Biol 962:83–93
Komori T (2019) Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int J Mol Sci 20(7):1694
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764
Lai Y, Kacal M, Kanony M, Stukan I, Jatta K, Kis L, Norberg E, Vakifahmetoglu-Norberg H, Lewensohn R, Hydbring P, Ekman S (2019) miR-100-5p confers resistance to ALK tyrosine kinase inhibitors crizotinib and lorlatinib in EML4-ALK positive NSCLC. Biochem Biophys Res Commun 511:260–265
Lai Z, Cao Y (2019) Plasma miR-200c-3p, miR-100-5p, and miR-1826 serve as potential diagnostic biomarkers for knee osteoarthritis: randomized controlled trials. Medicine 98:e18110
Li D, Tian Y, Yin C, Huai Y, Zhao Y, Su P, Wang X, Pei J, Zhang K, Yang C, Dang K, Jiang S, Miao Z, Li M, Hao Q, Zhang G, Qian A (2019) Silencing of lncRNA AK045490 promotes osteoblast differentiation and bone formation via beta-catenin/TCF1/Runx2 signaling axis. International journal of molecular sciences. Int J Mol Sci 20:6229
Li WD, Yan CP, Wu Y, Weng ZB, Yin FZ, Yang GM, Cai BC, Chen ZP (2014) Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae. Phytomedicine 21:400–405
Li ZR, Cheng LM, Wang KZ, Yang NP, Yang SH, He W, Wang YS, Wang ZM, Yang P, Liu XZ, Luo YZ, Sun W, Wang HT, Zheng LZ, Wang XL, Qin L (2018) Herbal Fufang **an Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-a first multicentre, randomised, double-blind, placebo-controlled clinical trial. J Orthop Translat 12:36–44
Lin X, Li L, Wu S, Tian J, Zheng W (2019) Activation of GPR30 promotes osteogenic differentiation of MC3T3-E1 cells: an implication in osteoporosis. IUBMB Life 71:1751–1759
Lindsay BR, Olufade T, Bauer J, Babrowicz J, Hahn R (2016) Patient-reported barriers to osteoporosis therapy. Arch Osteoporos 11:19
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408
Matsuoka K, Park KA, Ito M, Ikeda K, Takeshita S (2014) Osteoclast-derived complement component 3a stimulates osteoblast differentiation. J Bone Miner Res 29:1522–1530
Nabavi N, Saidy NRN, Venalainen E, Haegert A, Parolia A, Xue H, Wang Y, Wu R, Dong X, Collins C, Crea F, Wang Y (2017) miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer. Sci Rep:7, 4079
Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765–771
Tomasevic-Todorovic S, Vazic A, Issaka A, Hanna F (2018) Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study. Open Access Rheumatol 10:61–66
Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y (2016a) Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit 22:226–233
Wang L, Li Y, Guo Y, Ma R, Fu M, Niu J, Gao S, Zhang D (2016b) Herba Epimedii: an ancient Chinese herbal medicine in the prevention and treatment of osteoporosis. Curr Pharm Des 22:328–349
Wang Q, Li Y, Zhang Y, Ma L, Lin L, Meng J, Jiang L, Wang L, Zhou P, Zhang Y (2017) LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. Biomed Pharmacother 89:1178–1186
Wu H, Zhong Q, Wang J, Wang M, Fang F, **a Z, Zhong R, Huang H, Ke Z, Wei Y, Feng L, Shi Z, Sun E, Song J, Jia X (2017) Beneficial effects and toxicity studies of **an-ling-gu-bao on bone metabolism in ovariectomized rats. Front Pharmacol 8:273
Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, Wang C, Geng X, Li B (2019) **an-Ling-Gu-Bao induced inflammatory stress rat liver injury: inflammatory and oxidative stress playing important roles. J Ethnopharmacol 239:111910
Wu X, Li Z, Yang Z, Zheng C, **g J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, **ao J, Liu M, Luo J (2012) Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-kappaB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. J Bone Miner Res 27:1298–1308
Yang D, Okamura H, Nakashima Y, Haneji T (2013) Histone demethylase Jmjd3 regulates osteoblast differentiation via transcription factors Runx2 and osterix. J Biol Chem 288:33530–33541
Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S (2011) Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J Bone Miner Res 26:2665–2671
Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, Qin LP, **n HL, Zhang QY, Li YM (2016) Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. J Ethnopharmacol 189:61–80
Zhou L, Song HY, Gao LL, Yang LY, Mu S, Fu Q (2019) MicroRNA1005p inhibits osteoclastogenesis and bone resorption by regulating fibroblast growth factor 21. Int J Mol Med 43:727–738
Acknowledgments
This study was supported by the National Natural Science Foundation of China (81774339), Traditional Chinese Medicine Bureau of Guangdong Province (20191066), and Major discipline research projects of Guangzhou University of Chinese Medicine in 2020 (XK2019012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
We declare that we have no conflict of interest.
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Ai, L., Yi, W., Chen, L. et al. **an-Ling-Gu-Bao protects osteoporosis through promoting osteoblast differentiation by targeting miR-100-5p/KDM6B/RUNX2 axis. In Vitro Cell.Dev.Biol.-Animal 57, 3–9 (2021). https://doi.org/10.1007/s11626-020-00530-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-020-00530-w